Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 857Wnt/β-catenin signaling in development and cancerColorectal Cancer Treatments and StudiesCancer Cells and Metastasis

The DOI matches its Crossref record; 275 of the 275 references it cites were found in a registry or an index.

Wnt signaling in colorectal cancer: pathogenic role and therapeutic target

Open access
Zhao, Hui, Ming, Tianqi, Tang, Shun, Ren, Shan, Yang, Han, Liu, Maolun, Tao, Qiu, Xu, Haibo·2022·Molecular Cancer

Abstract

Background: The Wnt signaling pathway is a complex network of protein interactions that functions most commonly in embryonic development and cancer, but is also involved in normal physiological processes in adults. The canonical Wnt signaling pathway regulates cell pluripotency and determines the differentiation fate of cells during development. The canonical Wnt signaling pathway (also known as the Wnt/β-catenin signaling pathway) is a recognized driver of colon cancer and one of the most representative signaling pathways. As a functional effector molecule of Wnt signaling, the modification and degradation of β-catenin are key events in the Wnt signaling pathway and the development and progression of colon cancer. Therefore, the Wnt signaling pathway plays an important role in the pathogenesis of diseases, especially the pathogenesis of colorectal cancer (CRC). Objective: Inhibit the Wnt signaling pathway to explore the therapeutic targets of colorectal cancer. Methods: Based on studying the Wnt pathway, master the biochemical processes related to the Wnt pathway, and analyze the relevant targets when drugs or inhibitors act on the Wnt pathway, to clarify the medication ideas of drugs or inhibitors for the treatment of diseases, especially colorectal cancer. Results: Wnt signaling pathways include: Wnt/β-catenin or canonical Wnt signaling pathway, planar cell polarity (Wnt-PCP) pathway and Wnt-Ca 2+ signaling pathway. The Wnt signaling pathway is closely related to cancer cell proliferation, stemness, apoptosis, autophagy, metabolism, inflammation and immunization, microenvironment, resistance, ion channel, heterogeneity, EMT/migration/invasion/metastasis. Drugs/phytochemicals and molecular preparations for the Wnt pathway of CRC treatment have now been developed. Wnt inhibitors are also commonly used clinically for the treatment of CRC. Conclusion: The development of drugs/phytochemicals and molecular inhibitors targeting the Wnt pathway can effectively treat colorectal cancer clinically.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-022-01616-7

Cites

275 of 275 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Canonical and non-canonical Wnt signaling pathways
Fig. 1 Canonical and non-canonical Wnt signaling pathwaysCC BY · PubMed Central
Fig. 2 Canonical Wnt/β-catenin signaling pathway off and on
Fig. 2 Canonical Wnt/β-catenin signaling pathway off and onCC BY · PubMed Central
Fig. 3 Wnt signaling pathway and biochemical process
Fig. 3 Wnt signaling pathway and biochemical processCC BY · PubMed Central
Fig. 4 Wnt blocking drugs and pathway inhibitors
Fig. 4 Wnt blocking drugs and pathway inhibitorsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

4 retracted

Show all 275 references

Cited by

See all 857

Metadata

Authors
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H.
Affiliations
Chengdu University of Traditional Chinese Medicine (CN)
Corresponding author
Xu, Haibo
Venue
Molecular Cancer
Published
2022-07-14
Volume
21
Issue
1
Pages
144-144
ISSN
1476-4598 (ISSN-L)
OpenAlex
W4285391272
Cited by
857
References
275
Citations by year
2026: 151 · 2025: 276 · 2024: 245 · 2023: 169 · 2022: 15
FWCI
18.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81173598, 81573813)
  • Chengdu University of Traditional Chinese Medicine (GJJJ2021003)
  • Chengdu University
  • Sichuan Provincial Administration of Traditional Chinese Medicine (2021XYCZ007, 2021MS447)
  • Health Commission of Sichuan Province (21PJ107)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
Wnt signaling, colorectal cancer, Wnt/β-catenin signaling, β-catenin degradation, therapeutic target, Wnt inhibitors, cancer stemness, epithelial-mesenchymal transition, drug resistance, tumor microenvironment, phytochemicals
MeSH terms
Cell Movement, Colonic Neoplasms, Humans, Colorectal Neoplasms, Cell Line, Tumor, Cell Proliferation, beta Catenin, Epithelial-Mesenchymal Transition, Tumor Microenvironment, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. https://app.cochat.ai/papers/10.1186/s12943-022-01616-7
The paper
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022). Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Molecular Cancer. https://doi.org/10.1186/s12943-022-01616-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.